Comparative genomic hybridization in pediatric acute lymphoblastic leukemia

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Childhood acute lymphoblastic leukemia (ALL) diagnosis relies on cytogenetic analysis.
• Standard methods like trypsin and giemsa banding (GTG) can fail to yield metaphases for analysis.
• Subtle chromosomal abnormalities may be missed by conventional karyotyping.

Purpose of the Study:

• To evaluate the utility of comparative genomic hybridization (CGH) in diagnosing chromosomal abnormalities in childhood ALL.
• To assess CGH's effectiveness in cases with failed or normal GTG banding.
• To determine if CGH provides superior resolution compared to karyotyping for ALL.

Main Methods:

• Comparative genomic hybridization (CGH) was applied to bone marrow samples from 15 pediatric ALL patients.
• Samples included those with failed GTG banding, normal GTG karyotypes, and hyperdiploidy.
• CGH results were compared with conventional cytogenetic findings.

Main Results:

• CGH detected chromosomal abnormalities in 70% (7/10) of patients with failed GTG banding.
• CGH identified abnormalities in 67% (2/3) of patients with initially normal GTG karyotypes.
• CGH provided more accurate resolution than karyotyping for hyperdiploid samples, suggesting non-malignant cells were used for GTG.

Conclusions:

• CGH is highly effective in detecting chromosomal aberrations in childhood ALL, particularly when standard cytogenetics fails.
• The technique offers improved diagnostic accuracy and prognostic value.
• CGH is recommended for routine clinical cytogenetics in ALL diagnosis.